MONDAY, June 24, 2024 -- For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a...

TUESDAY, June 25, 2024 -- For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1...

COPENHAGEN, Denmark; June 27, 2024 – Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved...

TUESDAY, June 18, 2024 -- For children, longer sleep duration and earlier sleep onset are associated with lower blood pressure, according to a study...

TUESDAY, June 25, 2024 -- Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or...

FRIDAY, June 21, 2024 -- First-line ibrutinib is associated with better outcomes than chemoimmunotherapy among patients with chronic lymphocytic...

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally...

THURSDAY, June 20, 2024 -- Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy...

THURSDAY, June 20, 2024 -- For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with...

FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June...